| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Clarus IV-A, L.P. is a 10% Owner at Galera Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $26K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2019 | GRTX Galera Therapeutics, Inc. | 10% Owner | Buy | 250,000 | $12.00 | $3,000,000.00 | +17.5% |